Tue Sep 17 06:25:24 UTC 2024: ## AstraZeneca Insider Buys Shares, Company Declares Dividend

**London, UK -** Michel Demare, an insider at AstraZeneca PLC (LON:AZN), recently purchased 2,000 shares of the company’s stock on September 13th, at an average price of GBX 118 ($1.56) per share. The total transaction amounted to £2,360 ($3,117.57).

AstraZeneca, a leading biopharmaceutical company, has seen its stock open at £120.16 ($158.73) on Tuesday, with a 12-month low of GBX 9,461 ($124.98) and a 12-month high of £133.88 ($176.86). The company boasts a market cap of £186.25 billion, a P/E ratio of 3,851.28, a P/E/G ratio of 0.93, and a beta of 0.17.

AstraZeneca also declared a dividend on September 9th, with stockholders of record on August 8th receiving a dividend of GBX 77.60 ($1.03) per share. The ex-dividend date was Thursday, August 8th, representing a dividend yield of 0.64%. The company’s dividend payout ratio currently stands at 7,500.00%.

AstraZeneca focuses on developing, manufacturing, and commercializing prescription medicines for various conditions, including cardiovascular, renal, metabolism, and oncology. Some of their marketed products include Tagrisso, Imfinzi, Lynparza, and Crestor.

For further updates on AstraZeneca and other related companies, sign up for MarketBeat.com’s free daily email newsletter.

Read More